Organ Preservation Solutions Market
Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Press Release :
Global Organ Preservation Solutions Market: Overview
The drive for organ preservation solutions is strengthened by their growing role in the success of organ transplantation. These are aimed at maintaining donor organ quality, minimize reperfusion injury, and improve survival after transplantation. In the growing face of the need for organ transplantation particularly in patients with end-stage diseases, a range of organ perfusion techniques have attracted attention of the healthcare systems. Together with this, range of therapeutic additives or better perfusates have clinicians extend preservation times. Such advances are expanding the potential in the organ preservation solutions market. Growing body of research in hypothermic machine perfusion for applicability in cases of cardiac and lung transplantation is broadening the window of opportunities for players in the market. The research community is increasingly focusing on ischemia/reperfusion (I/R)-induced cellular injury to advance the clinical efficacy of technologies in the organ preservation solutions market.
The global organ preservation solutions market stood at US$0.06 bn in 2012 and was expected to have clocked a CAGR of 16.50% during 2013 – 2019 to surpass worth of US$0.20 bn by the period end.
Remarkable Survival Rates with Custodiol HTK Cements Its Market Potential
Based on the solution type, the report segments the overall organ preservation solutions market into siRNA transplant solutions, human biosystems solution (HBS), hypothermosol, RENOGRAPF, lifor, PERFADEX, viaspan, and custodiol histidine-tryptophan-ketoglutarate (HTK) solution.
Of these, custodiol HTK solution held the major share in the global organ preservation solutions market and grew at a rapid CAGR during 2013 – 2019. Extensive demand for cardiac preservation in cardiac transplantation has helped the segment to rise in prominence in the organ preservation solutions market. That aside, extensive clinical trials on the process have resulted in comparable patient survival with abdominal organ transplants. Custodiol HTK solutions are becoming popular due to their effectiveness in reducing hypoxic and cold-induced cell injury.
Hypothermic Perfusion to Gain Popularity in Organ Transplantation
The study bifurcates the organ preservation solutions market into static cold storage and hypothermic perfusion. Of the two, the former segment has led the pack and has remained the most common one for the past several years. They are used extensively in abdominal organ preservation. One of the salient benefits of the process is the protection that it provides during prolonged cold ischemia.
However, marked limitations have turned the scale of providers in organ preservation solutions market toward hypothermic perfusion. The segment will gather pace in its uptake in the coming years. One key trend that has helped propel the attention is their advantage over the other method for improving the outcomes of kidney transplant. Advances in hypothermic perfusion technology have reduced the rates of delayed graft function, propelling their potential in the organ preservation solutions market.
The key regions where the opportunities of the organ preservation solutions spread are Asia Pacific, Europe, and North America, in addition to an ‘others’ segment. Of all these, Europe held the major share in 2012. The prominence of the region to a great deal can be attributed to the rise in demand for organ transplantation as well as organ donors. The governments in the region have also taken several initiatives to promote organ transplantation. A large chunk of the regional revenues came from Spain.
Meanwhile, Asia Pacific is also expected to witness new growth factors on the back of the unmet demand to bridge the gap between organ donors and patients who need organ transplantation.
Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used. Increasing demand for organ transplantation procedures across the globe is expected to drive the growth of organ preservation solutions market. In addition, aging population will also propel the growth of organ preservation solutions market as the risk of organ failure in elderly people increases that augments the demand for organ transplants. Likewise, development of technologically advanced solutions for preserving organs will further accentuate the growth of organ preservation solutions market.
This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved. These solutions include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). The market for these solutions has been extensively analyzed based on number of organ transplant, efficiency and application area. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.
Based on the type of preservation techniques used to preserve organs, market has been segmented as hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). The market for these technologies has been extensively analyzed based on number of organ transplant, compatibility with solution and organs, and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.
Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for this segment. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.
The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global ultrasound devices market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.
The global organ preservation solutions market has been segmented as below:
Organ Preservation Solutions Market, by Solution
- Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
- Human BioSystems (HBS) Solution
- siRNA Transplant Solutions
Organ Preservation Solutions Market, by Preservation Technique
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
Organ Preservation Solutions Market, by Geography
- North America
- Rest of the World (RoW)